Merck drops depression drug
November 14, 2003US pharma company Merck has stopped development of a new depression drug in late-stage clinical trials, casting doubt over the …
US healthcare ‘in danger of collapse’
November 13, 2003The US healthcare system is in "imminent danger of collapse" and needs radical reform, according to one of the country's …
Slimmed down Bayer rules out merger
November 12, 2003Bayer has unveiled a radical reorganisation of its business, including a refocused pharmaceutical division, but ruled out looking for a …
GlaxoSmithKline to open biotech research centre
November 12, 2003GlaxoSmithKline is to create a new drug discovery group focused on biopharmaceuticals to capitalise on the potential of its large …
‘European FDA’ one step closer
November 6, 2003Europe looks set to emulate US medicines regulator the FDA by transferring responsibility from national agencies to a single centralised …
Lords reject ‘shambolic’ foundation plans
November 6, 2003The government's controversial plans to create foundation hospitals have been rejected by the House of Lords.Peers singled out for particular …
NHS launches ‘one-stop’ website
November 6, 2003A new one-stop NHS website portal for the public and patients has been officially launched by the government.The site has …
Supplementary prescribing
November 6, 2003NHS, healthcare, pharmacist, supplementary prescribing
Supplementary prescribing by pharmacists will soon become a reality. The first wave of pharmacy supplementary prescribers begin their courses this …
Foundation distrust
November 6, 2003NHS, foundation hospitals, healthcare
Despite fierce opposition from several areas, foundation hospitals look set to become a reality in 2004. But what will they …
Teva stretches lead in generics
November 5, 2003Sales and Marketing
Teva has agreed to acquire US generics company Sicor for $3.4 billion and increased its third quarter profits 63%, led …
Lilly resolves FDA manufacturing dispute
November 5, 2003Manufacturing and Production
Two Eli Lilly manufacturing sites have passed FDA inspections resolving a long-running dispute and paving the way for the launch …
Making the switch
November 5, 2003Sales and Marketing P, POM, switch
Switching is not a given and a successful POM to P transition requires considerable research and planning to extend unique …
HRT – Too great a risk ?
November 4, 2003Research and Development HRT, clinical trial
The last 15 months have seen the image of HRT change from a miraculous medicine to a risky range of …
Latest content
FibroFind appoints Lee Borthwick as CEO
